SECTION I: USE OF THE CLINICAL PRACTICE GUIDELINE
This Clinical Practice Guideline document is based uponthe best information available as of March 2009. It isdesigned to provide information and assist decisionmaking. It is not intended to define a standard of care, andshould not be construed as one, nor should it be interpreted as prescribing an exclusive course of management.
Variations in practice will inevitably and appropriatelyoccur when clinicians take into account the needs ofindividual patients, available resources, and limita-tions unique to an institution or type of practice. Everyhealth-care professional making use of these recom-mendations is responsible for evaluating the appropri-ateness of applying them in the setting of any particu-lar clinical situation. The recommendations forresearch contained within this document are generaland do not imply a specific protocol.
Kidney Disease: Improving Global Outcomes (KDIGO)makes every effort to avoid any actual or reasonablyperceived conflicts of interest that may arise as aresult of an outside relationship or a personal, profes-sional, or business interest of a member of the WorkGroup.
All members of the Work Group are required to com-plete, sign, and submit a disclosure and attestationform showing all such relationships that might beperceived or actual conflicts of interest. This docu-ment is updated annually and information is adjust-ed accordingly. All reported information is publishedin its entirety at the end of this document in the WorkGroup members’ Biographic and DisclosureInformation section, and is on file at the NationalKidney Foundation (NKF), Managing Agent forKDIGO.
KDIGO gratefully acknowledges the following sponsors that make our initiatives possible: Abbott, Amgen, BeloFoundation, Coca-Cola Company, Dole Food Company, Genzyme, Hoffmann-LaRoche, JC Penney, NATCO-TheOrganization for Transplant Professionals, National Kidney Foundation-Board of Directors, Novartis, Robertand Jane Cizik Foundation, Shire, Transwestern Commercial Services, and Wyeth. KDIGO is supported by aconsortium of sponsors and no funding is accepted for the development of specific guidelines.
完整版下载2009KDIGO临床实践指南:肾移植受者的诊治
肾脏亦是参与机体代谢的器官之一,尤其是在水、电解质与酸碱平衡的维持,代谢中...[详细]
造影剂肾病是碘造影剂应用过程中的重要并发症,也是医源性肾功能衰竭的重要组成...[详细]